单孔和单操作孔电视辅助胸腔镜手术在非小细胞肺癌根治术中的应用  

Application of uniportal and biportal video-assisted thoracoscopic surgery in radical resection of non-small cell lung cancer

作　　者：邴钟兴[1] 郑志博 张家齐[1] Bing Zhongxing;Zheng Zhibo;Zhang Jiaqi(Department of Thoracic Surgery,PUMCH Hospital,Beijing 100005,China)

机构地区：[1]北京协和医院胸外科,北京100005

出　　处：《中国医刊》2021年第12期1308-1311,共4页Chinese Journal of Medicine

基　　金：吴阶平医学基金会胸腹部肿瘤精准治疗基金(320.6750.19092-43)。

摘　　要：目的比较单孔和单操作孔电视辅助胸腔镜手术(video-assisted thoracoscopic surgery,VATS)在非小细胞肺癌(nonsmall cell lung cancer,NSCLC)中的应用效果。方法选取2019年6月至2020年10月在北京协和医院就诊并接受VATS治疗的NSCLC患者97例,根据手术方法的不同分为单孔组(46例)和单操作孔组(51例)。比较两组患者的一般资料、NSCLC病灶指标、术中术后观察指标以及并发症发生情况。结果两组患者一般临床资料,NSCLC病灶指标,手术时间、术中出血量、清扫淋巴结数目、引流管留置时间及术后并发症发生率比较差异均无显著性(P>0.05)。单孔组引流液总量、术后住院时间、术后疼痛视觉模拟量表(visual analogue scale,VAS)评分低于单操作孔组,差异有显著性(P<0.05)。结论单孔和单操作孔VATS应用于NSCLC的治疗均安全可行,且单孔VATS术后疼痛程度更轻、住院时间更短,值得临床应用。Objective To analyze and compare the application effect of uniportal and biportal video-assisted thoracoscopic surgery(VATS)in the application of non-small cell lung cancer(NSCLC).Method A total of 97 patients with NSCLC admitted to our hospital from June 2019 to October 2020 were selected as the research objects.According to different surgical methods,the patients were divided into uniportal group(n=46)and biportal group(n=51).The general clinical data,NSCLC indexes,intraoperative and postoperative observation indexes and the incidence of complications were compared between the two groups.Result There were no significant differences in general clinical data,NSCLC indexes,intraoperative observation indexes and postoperative complication rate between two groups(P>0.05).There was no significant difference in the drainage tube placement time between the two groups(P>0.05),the total amount of drainage fluid,postoperative hospital stay,postoperative 1d and 3d visual analogue scale(VAS)in the uniportal group were all lower than those in the biportal group,with statistical significance(P<0.05).Conclusion The application of uniportal and biportal VATS in NSCLC is safe and feasible.The uniportal group has lower postoperative VAS score and shorter hospital stay,which can reduce the economic burden of patients and has a broad clinical application prospect.

关 键 词：电视辅助胸腔镜手术 非小细胞肺癌 术后并发症 

分 类 号：R734.2[医药卫生—肿瘤]